Combination Therapy May Revive Prospects for ‘Embattled’ Breast Cancer Drugs
Researchers identified a protein that cancer cells use as a shield to protect the PI3K pathway against targeted drugs, and showed that blocking this protein allowed previously ineffective therapies to slow cancer cell growth and shrink tumors.
![A breast cancer tumor](/sites/default/files/styles/news_card__image/public/fields/field_insert_file/news/breast_cancer_tumor.jpg)